BACKGROUND: Tranexamic acid is a synthetic lysine analog used for management of bleeding disorders. The objective of this study was first to develop a method for measurement of tranexamic acid in human serum using liquid chromatography coupled to ion-trap mass spectrometry (LC-MS/MS), and then to validate it throughout a wide range of concentrations allowing quantification in patients receiving tranexamic acid infusion during surgery. METHODS: Serum samples (100 microL) were subjected to protein precipitation with perchloric acid, and after pH adjustment, tranexamic acid and internal standard were separated on a C(18) column and isocratically eluted using a mobile phase constituted of formate buffer/acetonitrile (95:5, v/v). Tranexamic acid was ionized by electrospray in positive mode. Parent [M+H](+) ions were m/z 158.0 for tranexamic acid and m/z 144.0 for IS. The most intense product ion of tranexamic acid (m/z 122.7) and IS (m/z 126.0) were used for quantification. RESULTS: The assay was accurate and precise over the range of 1.0 (lower limit of quantification) to 200.0 microg/mL (upper limit of quantification), and has been successfully applied to study the clinical pharmacokinetics in two volunteers undergoing cardiac surgery. CONCLUSION: A reliable method for quantification of tranexamic acid for analysis in clinical studies was obtained. Copyright 2010 Elsevier B.V. All rights reserved.
BACKGROUND:Tranexamic acidis a synthetic lysine analog used for management of bleeding disorders. The objective of this study was first to develop a method for measurement of tranexamic acid in human serum using liquid chromatography coupled to ion-trap mass spectrometry (LC-MS/MS), and then to validate it throughout a wide range of concentrations allowing quantification in patients receiving tranexamic acid infusion during surgery. METHODS: Serum samples (100 microL) were subjected to protein precipitation with perchloric acid, and after pH adjustment, tranexamic acid and internal standard were separated on a C(18) column and isocratically eluted using a mobile phase constituted of formate buffer/acetonitrile (95:5, v/v). Tranexamic acid was ionized by electrospray in positive mode. Parent [M+H](+) ions were m/z 158.0 for tranexamic acid and m/z 144.0 for IS. The most intense product ion of tranexamic acid (m/z 122.7) and IS (m/z 126.0) were used for quantification. RESULTS: The assay was accurate and precise over the range of 1.0 (lower limit of quantification) to 200.0 microg/mL (upper limit of quantification), and has been successfully applied to study the clinical pharmacokinetics in two volunteers undergoing cardiac surgery. CONCLUSION: A reliable method for quantification of tranexamic acid for analysis in clinical studies was obtained. Copyright 2010 Elsevier B.V. All rights reserved.
Authors: Homa K Ahmadzia; Naomi L C Luban; Shuhui Li; Dong Guo; Adam Miszta; Jogarao V S Gobburu; Jeffrey S Berger; Andra H James; Alisa S Wolberg; John van den Anker Journal: Am J Obstet Gynecol Date: 2020-11-26 Impact factor: 10.693
Authors: Nerdy Nerdy; Linda Margata; Bunga Mari Sembiring; Selamat Ginting; Effendy De Lux Putra; Tedy Kurniawan Bakri Journal: Molecules Date: 2021-11-19 Impact factor: 4.411
Authors: Adam Miszta; Homa K Ahmadzia; Naomi L C Luban; Shuhui Li; Dong Guo; Lori A Holle; Jeffrey S Berger; Andra H James; Jogarao V S Gobburu; John van den Anker; Bas de Laat; Alisa S Wolberg Journal: J Thromb Haemost Date: 2020-12-26 Impact factor: 5.824
Authors: Eduarda M P Silva; Luisa Barreiros; Sara R Fernandes; Paula Sá; João P Prates Ramalho; Marcela A Segundo Journal: Pharmaceuticals (Basel) Date: 2021-11-23